WC
BIOS

Wealthspring Capital’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Wealthspring Capital’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-39,450
Closed -$395K – 321
2022
Q3 		$395K Hold
39,450
– – 0.08% 345
2022
Q2 		$394K Buy
+39,450
New +$392K 0.07% 353

Other funds holding BIOS

SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
SV
Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return

Wealthspring Capital's BIOS Position: Q4 2022 in Review

Wealthspring Capital sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2022, closing a stake of 39,450 shares — an estimated $395K sold.

Wealthspring Capital first reported a position in BIOS in Q2 2022 and held it in 2 quarters. The position peaked at $395K in Q3 2022. 67 funds tracked by Wall St. Rank hold BIOS as of Q4 2022.

  • Wealthspring Capital reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Wealthspring Capital sold 39,450 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $395K.
  • Wealthspring Capital first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q2 2022 and held it in 2 quarters.
  • Wealthspring Capital's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $395K in Q3 2022.
  • 67 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on Wealthspring Capital's 13F filing for Q4 2022, filed 8 Feb 2023.